Control Bionics Ltd.ASX: CBL

Joint venture with NextLevel Assistive Technology

· Issued by Control Bionics Ltd.

Filed with ASX · · 3 pages · English

Summary by 6ix AI

Control Bionics Ltd. has announced a strategic joint venture with NextLevel Assistive Technology to enhance its iOS speech-generating device platform in the United States. The agreement allows Control Bionics to manufacture, distribute, and sell new iOS-based speech-generating devices while acting as the FDA Manufacturer of Record. This partnership aims to leverage NextLevel's designs and Control Bionics' distribution network to tap into the growing US augmentative and assistive communication market. Control Bionics is currently negotiating with multiple US distributors to expand its market presence without significant capital investment.

Written by 6ix AI from the company’s filing. How 6ix writes summaries

Control Bionics Ltd. on 6ix

In the deck

Earlier from Control Bionics

Later from Control Bionics

All Control Bionics news releases